Related Experiment Video

Updated: Jun 16, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Postvaccination thrombocytopenia in Canada

Laura J Sauvé1, Julie Bettinger, David Scheifele

  • 1Vaccine Evaluation Center, BC Children's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada. lsauve@cw.bc.ca

The Pediatric Infectious Disease Journal
|February 18, 2010
PubMed

Insights

Postvaccination thrombocytopenia in children is rare, with most cases showing mild symptoms and good recovery. This study analyzed 107 pediatric cases, finding minimal severe bleeding and high recovery rates within three months.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Vaccine Safety

Background:

  • Postvaccination thrombocytopenia (PVT) is a rare adverse event following immunization.
  • Understanding the clinical course and outcomes of PVT in children is crucial for vaccine safety monitoring.

Purpose of the Study:

  • To analyze active surveillance data of children hospitalized with PVT.
  • To describe the clinical presentation, severity, and recovery patterns of PVT in pediatric patients.

Main Methods:

  • Analysis of active surveillance data from 12 Canadian tertiary-care hospitals.
  • Inclusion of pediatric cases of PVT reported since 1992.

Main Results:

  • 107 pediatric cases of PVT were reported.
  • 96% of children were symptomatic, but only 2 experienced severe bleeding.
  • 26% had normal platelet counts at hospital discharge, and 93% recovered within 3 months.

Conclusions:

  • PVT in children is generally associated with mild symptoms and a favorable prognosis.
  • Active surveillance systems are effective in monitoring rare vaccine-related adverse events.
  • The study highlights the safety profile of vaccines regarding thrombocytopenic events in pediatric populations.

More Related Videos

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...